Skin tumours in immunosuppressed patients.
D000293:Adolescent; D000328:Adult; D000493:Allopurinol / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects; D001379:Azathioprine / Q000009:adverse effects; D002280:Basal Cell Carcinoma / Q000139:chemically induced; D002294:Carcinoma, Squamous Cell / Q000139:chemically induced; D003520:Cyclophosphamide / Q000009:adverse effects; D005153:Facial Neoplasms / Q000139:chemically induced; D005260:Female; D006225:Hand; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D007636:Keratoacanthoma / Q000139:chemically induced; D007642:Keratosis / Q000139:chemically induced; D016030:Kidney Transplantation; D007866:Leg; D008048:Lip Neoplasms / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D009669:Nose Neoplasms / Q000139:chemically induced; D011183:Postoperative Complications; D012878:Skin Neoplasms / Q000139:chemically induced*; D014184:Transplantation, Homologous
D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D000493:Allopurinol; D003520:Cyclophosphamide; D001379:Azathioprine